DEVELOPMENT SITE ONLY
Please use current guidelines available on the UHNM intranet for patient treatment
Please use current guidelines available on the UHNM intranet for patient treatment
RECOGNITION AND ASSESSMENT
Symptoms and signs
- Severe diarrhoea, tenesmus
- Abdominal pain
- Anorexia, weight loss
- Malaise
- Variable amount of blood in stool
- Dehydration
- Tachycardia
- Fever
- Anaemia
Life-threatening features
- Severe sepsis/septic shock
- Toxic dilatation of colon
- Perforation of colon
- Profound electrolyte disturbance
- Massive haemorrhage
- Obvious weight loss
- Secondary multi-organ failure
Investigations
- FBC
- U&E
- LFT
- CRP
- Blood glucose
- Abdominal X-ray
- Erect chest X-ray – look for gas under diaphragm
- Stool culture (Salmonella, Shigella, Campylobacter), Clostridium difficile toxin
- Crossmatch: group and save
- Arterial blood gases
Differential diagnosis
- Bacterial and amoebic colitis (history of travel)
- Pseudomembranous colitis (history of antimicrobial use)
- Diverticular disease
- Ischaemic colitis
- Bowel cancer
- Abdominal lymphoma
- Radiation colitis
- Ileocaecal TB
IMMEDIATE TREATMENT
Logistics
- If needed, contact on-call consultant gastroenterologist
- In patients with life-threatening features inform duty surgical team
- Barrier nurse
- inflammatory bowel disease can at first be indistinguishable from infective diarrhoea
- Admit to GI ward
Drugs and fluid
- Establish IV access and correct dehydration/electrolyte disturbance
- If Hb <80 g/L, give blood transfusion
- 4 units plus an extra unit for each g/L below 80
- Hydrocortisone 200 mg 8-hrly by slow IV injection over 1 min
- Ensure all patients receive prophylactic dalteparin 5000 units once daily
- If not improving either clinically or biochemically after 48 hr, consider escalation therapy with:
- either ciclosporin IV (unlicensed and rarely used) or infliximab IV only after discussion with consultant gastroenterologist or via a consensus opinion in IBD MDT (contact IBD Nurses for further information)
- If still no improvement by day 5, consider surgical opinion
DO NOT GIVE anti-diarrhoeal drugs in acute phase - they increase the risk of toxic dilatation
DO NOT PERFORM barium enema or colonoscopy in acute phase - there is a high risk of perforation of the colon
SUBSEQUENT MANAGEMENT
- Once infective element has been excluded, relax barrier nursing restrictions
- Ensure patient discussed with consultant gastroenterologist
If improving
- Substitute prednisolone (not enteric coated) 40 mg oral daily in place of hydrocortisone
- taper dose by 5mg every week
- co-prescribe calcium and vitamin D (e.g. Adcal D3® 2 tablets daily) whilst on prednisolone
- Start restricted oral feeding. Seek dietetic opinion
- Give mesalazine (Octasa® MR) 800 mg oral 8-hrly
- For distal disease, consider hydrocortisone foam enema 10% 12–24 hrly for 2–3 weeks
- If extent and severity of inflammation not apparent from supine plain abdominal X-ray
- consult with consultant gastroenterologist to plan colonoscopy in convalescent phase
If not improving
- If no improvement after 48 hr, consider escalation therapy with:
- either IV ciclosporin (unlicensed) or infliximab
- only after discussion with a consultant gastroenterologist
- If still no improvement by day 5, consider surgery
MONITORING TREATMENT
2-hrly
- Temperature
- Pulse
- BP
- Respiration
Twice daily
- Abdominal examination
- look for local peritonism and check bowel sounds
- Measure abdominal girth
Daily
- FBC, U&E, stool culture
- Abdominal X-ray
- look for free abdominal gas or colonic dilatation >6 cm
- Count stools and inspect for blood
Alternate days
- Erect chest X-ray: look for gas under diaphragm
DISCHARGE AND FOLLOW-UP
Plan home treatment regimen
- Prednisolone (not enteric coated)
- taper daily dosage by 5 mg each week to zero or previous maintenance dosage
- co-prescribe calcium and vitamin D (e.g. Adcal D3® 2 tablets daily) whilst on prednisolone
- If distal disease, hydrocortisone foam enema 10% 12–24 hrly
- Mesalazine (Octasa® MR), usually 800 mg 8-hrly but higher doses (up to 4.8 g/day) can be used if needed
- Nutritional support, as advised by dietitian
Follow-up
- If outpatient colonoscopy not already performed, arrange in consultation with consultant gastroenterologist
- Arrange follow-up in gastrointestinal outpatient clinic after 4 weeks
- Give patient information literature and encourage membership of Crohn's and Colitis UK
- Inform IBD Nurses of admission, especially if new diagnosis